Letter
Nature 439, 84-88 (5 January 2006) | doi:10.1038/nature04372; Received 1 August 2005; Accepted 13 October 2005
Generation of a functional mammary gland from a single stem cell
Mark Shackleton1,2, François Vaillant1,2, Kaylene J. Simpson3,6, John Stingl4,5, Gordon K. Smyth1, Marie-Liesse Asselin-Labat1,2, Li Wu1, Geoffrey J. Lindeman1,2 and Jane E. Visvader1,2
The existence of mammary stem cells (MaSCs) has been postulated from evidence that the mammary gland can be regenerated by transplantation of epithelial fragments in mice1, 2, 3. Interest in MaSCs has been further stimulated by their potential role in breast tumorigenesis4. However, the identity and purification of MaSCs has proved elusive owing to the lack of defined markers. We isolated discrete populations of mouse mammary cells on the basis of cell-surface markers and identified a subpopulation (Lin-CD29hiCD24+) that is highly enriched for MaSCs by transplantation. Here we show that a single cell, marked with a LacZ transgene, can reconstitute a complete mammary gland in vivo. The transplanted cell contributed to both the luminal and myoepithelial lineages and generated functional lobuloalveolar units during pregnancy. The self-renewing capacity of these cells was demonstrated by serial transplantation of clonal outgrowths. In support of a potential role for MaSCs in breast cancer, the stem-cell-enriched subpopulation was expanded in premalignant mammary tissue from MMTV-wnt-1 mice and contained a higher number of MaSCs. Our data establish that single cells within the Lin-CD29hiCD24+ population are multipotent and self-renewing, properties that define them as MaSCs.
- The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050,
- Bone Marrow Research Laboratories, Royal Melbourne Hospital, Parkville, Victoria 3050,
- Department of Biochemistry and Molecular Biology, The University of Melbourne, Victoria 3010, Australia
- Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada
- Stem Cell Technologies Inc., 570 West 7th Avenue, Suite 400, Vancouver, British Columbia V5Z 1B3, Canada
- †Present address: Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA
Correspondence to: Geoffrey J. Lindeman1,2Jane E. Visvader1,2 Correspondence and requests for materials should be addressed to J.E.V. (Email: visvader@wehi.edu.au) or G.J.L. (Email: lindeman@wehi.edu.au).
Received 1 August 2005 | Accepted 13 October 2005
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriersNature Medicine Article (01 Aug 2009)
Purification and unique properties of mammary epithelial stem cellsNature Letters to Editor (23 Feb 2006)
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiationNature Cell Biology Letter (01 Feb 2007)
See all 17 matches for Research
